Grace Therapeutics (GRCE) Stock Price & Financial Analysis
Grace Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Grace Therapeutics
What is the current stock price for GRCE?
As of the latest trading session, GRCE stock trades at $2.38. The 52-week range is $1.79–$5.18, with a day range of $2.21–$2.38.
What is the P/E ratio for GRCE?
The P/E ratio (Price-to-Earnings) for GRCE is shown in the Key Statistics section. This valuation metric helps compare Grace Therapeutics, Inc. to industry peers.
Does GRCE pay dividends?
Grace Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for GRCE?
Based on 1 analyst, the consensus for GRCE is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of GRCE?
Grace Therapeutics's market capitalization is $40.3M, classifying it as a micro-cap company. Grace Therapeutics operates in the Healthcare sector within the Biotechnology industry.